Literature DB >> 12054662

Esterification of the propionate groups promotes alpha/beta hemoglobin chain homogeneity of CN-hemin binding.

Therese M Jennings1, Melisenda J McDonald.   

Abstract

This study examines the post-translational role of peripheral propionate groups in the incorporation of the Fe-protoporphryin IX heme into nascent alpha- and beta-globin chains. Human apohemoglobin (a heme-free alpha/beta dimer) in 0.05 M potassium phosphate buffer, pH 7, at 20 degrees C was titrated with either CN-protohemin (native heme with two peripheral propionate groups), or CN-dimethylester hemin (a modified heme with two methyl ester groups in place of the propionate groups). Soret spectrophotometric CN-hemin titrations confirmed that a spectral shift resulted upon binding of protohemin, but no spectral shift occurred upon binding the dimethylester derivative. Recent studies have correlated a Soret spectral shift with the preferential heme binding to the alpha subunit of apohemoglobin. The absence of a Soret wavelength shift (in conjunction with molecular modeling) presented here suggested that the modification of heme propionate groups prevented the formation of an alpha-heme/beta-globin intermediate, a requisite step in the normal assembly of functional hemoglobin.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12054662     DOI: 10.1016/S0006-291X(02)00394-7

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  2 in total

1.  Temperature dependent soret spectral band shifts accompany human CN-mesohemoglobin assembly.

Authors:  Priyani V Fonseka; Gayathri Vasudevan; Lisa-Jo Ann Clarizia; Melisenda J McDonald
Journal:  Protein J       Date:  2007-06       Impact factor: 2.371

2.  Soret spectral and bioinformatic approaches provide evidence for a critical role of the alpha -subunit in assembly of tetrameric hemoglobin.

Authors:  Gayathri Vasudevan; Melisenda J McDonald
Journal:  Protein J       Date:  2006-01       Impact factor: 4.000

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.